TP53 and non-small cell lung carcinoma: Finally, the authors identified SMAD4 as a critical regulator: its loss in TP53-deficient NSCLC cells promoted neuroendocrine differentiation via ASCL1 upregulation, even in the absence of RB1 alterations.